CompletedNCT00671632
Ramelteon, triazolam or placebo and misuse potential in people with past polydrug use
About this title
Read the official source — NCT00671632Medication studyAges 18–60United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: 18 years to 60 years.
- Listed locations
- BaltimoreSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateJune 2003
- Recruitment status
- Completed
- Enrollment listed in the registry
- 14
- Sponsor
- Takeda
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 60 Years
- Official registry ID
- NCT00671632
- Official title
Show the full official title
A Randomized, Single Center, Double-Blind, Multiple-Dose, Placebo-Controlled, Crossover, Double-Dummy Study of The Acute Behavioral and Subjective Effects of Ramelteon in Subjects With a History of Polydrug Abuse.
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Baltimore
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Takeda.
Did this study involve medication?
Yes. The study involved medication, including Ramelteon, triazolam, and placebo (56 possible combinations total).
Who was this study for?
Listed age limits: 18 years to 60 years.
